• Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Tempus PurIST℠ Pancreatic Cancer Test
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
  • Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
  • Neurotrophic Receptor Tyrosine Kinase 1 (NTRK1) Gene Mutation Analysis (Translocation)
  • MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
Medical Test

Additional Testing
Access to Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq) is restricted.
Loading...